Advertisement

Somatostatin pp 285-290 | Cite as

Somatostatin, Clearance and Inhibition of Gastric Acid Secretion in Duodenal Ulcer Patients

  • Mats Mogard
  • Vern Maxwell
  • Terry Reedy
  • Gary Van Deventer
  • Janet Elashoff
  • John Walsh
Part of the Serono Symposia, USA book series (SERONOSYMP)

Abstract

Somatostatin is one of several gastrointestinal peptides of potential physiological significance in the inhibitory regulation of gastric acid secretion. It is produced and released in the gastric mucosa and exogenous administration of this peptide strongly inhibits acid secretion stimulated by a variety of secretagogues in man (1).

Keywords

Acid Secretion Gastric Acid Secretion Acid Output Ulcer Patient Duodenal Ulcer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Creutzfeldt W, Arnold R. Somatostatin and the stomach: exocrine and endocrine aspects. Metabolism 1978; 27: 1309–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Konturek SJ, Swierczek J, Kwiecieu N, et al. Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients. Dig Dis Sci 1977; 11: 981–8.Google Scholar
  3. 3.
    Fordtran JS, Walsh JH. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and patients with duodenal ulcer. J Clin Invest 1973; 52: 645–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Seal A, Yamada T, Debas H, et al. Somatostatin 14 and 28: clearance and potency on gastric function in dogs. Am J Physiol 1982; 243: G97102.Google Scholar
  5. 5.
    Walsh JH. Radioimmunoassay of gastrin. In: Rothfield B, ed. Nuclear medicine in vitro. Philadelphia: Lippincott, 1974: 231–48.Google Scholar
  6. 6.
    Colturi JT, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release and islet function. J Clin Invest 1984; 74: 417–23.PubMedCrossRefGoogle Scholar
  7. 7.
    Sheppard M, Shapiro B, Pimstone B, et al. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 1979; 48: 50–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Mats Mogard
    • 1
  • Vern Maxwell
    • 1
  • Terry Reedy
    • 1
  • Gary Van Deventer
    • 1
  • Janet Elashoff
    • 1
  • John Walsh
    • 1
  1. 1.Center for Ulcer Research and EducationV. A. Wadsworth Medical Center and UCLALos AngelesUSA

Personalised recommendations